Development of a solid dosage platform for the oral delivery of bilayer vesicles

Eur J Pharm Sci. 2017 Oct 15:108:71-77. doi: 10.1016/j.ejps.2017.06.014. Epub 2017 Jun 12.

Abstract

Within this work, we develop vesicles incorporating sub-unit antigens as solid dosage forms suitable for the oral delivery of vaccines. Using a combination of trehalose, dextran and mannitol, freeze-dried oral disintegrating tablets were formed which upon rehydration release bilayer vesicles incorporating antigen. Initial studies focused on the optimisation of the freeze-dry cycle and subsequently excipient content was optimised by testing tablet hardness, disintegration time and moisture content. The use of 10% mannitol and 10% dextran produced durable tablets which offered strong resistance to mechanical damage yet appropriate disintegration times and dispersed to release niosomes-entrapping antigen. From these studies, we have formulated a bilayer vesicle vaccine delivery system as rapid disintegrating tablets and capsules.

Keywords: Liposomes; Niosomes; Oral disintegrating tablets; Oral vaccines; Vesicles.

MeSH terms

  • Administration, Oral
  • Antigens, Viral / administration & dosage*
  • Antigens, Viral / immunology
  • Chemistry, Pharmaceutical
  • Dextrans / chemistry
  • Drug Delivery Systems
  • Drug Stability
  • Excipients / chemistry
  • Freeze Drying
  • Hardness
  • Humans
  • Influenza A Virus, H3N2 Subtype / immunology
  • Influenza Vaccines / administration & dosage*
  • Influenza Vaccines / chemistry
  • Liposomes / metabolism
  • Mannitol / chemistry
  • Nanoparticles / chemistry
  • Particle Size
  • Solubility
  • Tablets
  • Trehalose / chemistry

Substances

  • Antigens, Viral
  • Dextrans
  • Excipients
  • Influenza Vaccines
  • Liposomes
  • Tablets
  • Mannitol
  • Trehalose